XML 64 R50.htm IDEA: XBRL DOCUMENT v3.24.2.u1
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 06, 2023
Jan. 23, 2024
Jun. 30, 2023
Jun. 15, 2023
Apr. 24, 2023
Mar. 17, 2023
Feb. 28, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2021
Stockholders' equity     $ 43,669,058         $ 32,119,574 $ 43,669,058 $ 32,119,574 $ 43,669,058 $ 36,043,028 $ 39,284,295 $ 34,546,682 $ 44,007,783 $ 4,379,463
Accumulated deficit               (96,101,634)   (96,101,634)   (91,644,233) (66,232,813)      
Working capital                       12,285,310        
Revenue               13,206,717 12,363,429 27,791,190 24,713,206 53,376,874 50,347,652      
Net loss                   (4,457,401) (1,441,393) (18,542,654) (13,830,371)      
Net cash used in operations                       14,998,919        
Repayment of outstanding Facility                       1,908,195        
Equity method investment aggregate cost $ 3,950,000                              
Asset acquisition   $ 637,080                            
Building Acquision [Member]                                
Cash 3,950,000       $ 1,054,872                      
Equity method investment aggregate cost $ 2,000,020                              
Greece [Member]                                
Revenue               12,912,561 $ 11,582,138 27,138,133 $ 23,496,370 50,526,307 $ 49,812,839      
Cash       $ 109,330                        
Intangible assets       425,411                        
Issuable stock amount       $ 316,081                        
Shares issued       99,710                        
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                                
Working capital               $ 8,593,711   8,593,711            
Net cash used in operations                   $ 4,622,989            
Cash     873,600                          
Issuable stock amount     $ 138,667                 $ 138,667        
Shares issued     46,377                          
Asset acquision             $ 5,469,787                  
Secured Promissory Note             $ 4,457,520                  
Zip Doctor Inc [Member]                                
Cash           $ 150,000                    
Payment in fees           8,788                    
Intangible assets           $ 158,788                    
Cloudscreen [Member]                                
Cash   317,880                            
Total purchase price amount   $ 637,080                            
Shares of common stock issued   280,000                            
Shares of common fair value   $ 319,200                            
Asset acquisition   $ 637,080